Order Article Reprints

Müller L, Dabbiru VAS, Rutten L, Bos R, Zahn R, Handtke S, Thiele T, Palicio M, Esteban O, Broto M, et al. Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT. Vaccines. 2025; 13(1):3. https://doi.org/10.3390/vaccines13010003

Müller, Luisa, Venkata A. S. Dabbiru, Lucy Rutten, Rinke Bos, Roland Zahn, Stefan Handtke, Thomas Thiele, Marta Palicio, Olga Esteban, Marta Broto, and et al. 2025. "Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT" Vaccines 13, no. 1: 3. https://doi.org/10.3390/vaccines13010003

Müller, L., Dabbiru, V. A. S., Rutten, L., Bos, R., Zahn, R., Handtke, S., Thiele, T., Palicio, M., Esteban, O., Broto, M., Gordon, T. P., Greinacher, A., Wang, J. J., & Schönborn, L. (2025). Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT. Vaccines, 13(1), 3. https://doi.org/10.3390/vaccines13010003